Search

Your search keyword '"Panichi, Vincenzo"' showing total 310 results
Start Over "Panichi, Vincenzo"
310 results on '"Panichi, Vincenzo"'

102. Caffeic Acid, a Phenol Found in White Wine, Modulates Endothelial Nitric Oxide Production and Protects from Oxidative Stress-Associated Endothelial Cell Injury

Author

Migliori, Massimiliano, primary, Cantaluppi, Vincenzo, additional, Mannari, Claudio, additional, Bertelli, Alberto A. E., additional, Medica, Davide, additional, Quercia, Alessandro Domenico, additional, Navarro, Victor, additional, Scatena, Alessia, additional, Giovannini, Luca, additional, Biancone, Luigi, additional, and Panichi, Vincenzo, additional

Published
2015
Full Text
View/download PDF

104. A Pharmacoeconomic Analysis of Phosphate Binders Cost-Effectiveness in the RISCAVID Study

Author

Panichi, Vincenzo, primary, Rosati, Alberto, additional, Di Giorgio, Adriana, additional, Scatena, Alessia, additional, Bigazzi, Roberto, additional, Grazi, Giovanni, additional, Migliori, Massimiliano, additional, Paoletti, Sabrina, additional, Manca Rizza, Giovanni, additional, Casani, Aldo, additional, Sgambato, Alessandro, additional, and Ruggeri, Matteo, additional

Published
2015
Full Text
View/download PDF

107. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis

Author

Cantaluppi, Vincenzo, primary, Medica, Davide, additional, Mannari, Claudio, additional, Stiaccini, Giulia, additional, Figliolini, Federico, additional, Dellepiane, Sergio, additional, Quercia, Alessandro Domenico, additional, Migliori, Massimiliano, additional, Panichi, Vincenzo, additional, Giovannini, Luca, additional, Bruno, Stefania, additional, Tetta, Ciro, additional, Biancone, Luigi, additional, and Camussi, Giovanni, additional

Published
2014
Full Text
View/download PDF

121. Automatic Adaptive System Dialysis for Hemodialysis-Associated Hypotension and Intolerance: A Noncontrolled Multicenter Trial

Author

Colì, Luigi, primary, La Manna, Gaetano, additional, Comai, Giorgia, additional, Ursino, Mauro, additional, Ricci, Davide, additional, Piccari, Matteo, additional, Locatelli, Francesco, additional, Di Filippo, Salvatore, additional, Cristinelli, Luciano, additional, Bacchi, Massimo, additional, Balducci, Alessandro, additional, Aucella, Filippo, additional, Panichi, Vincenzo, additional, Ferrandello, Francesco Paolo, additional, Tarchini, Renzo, additional, Lambertini, Domenica, additional, Mura, Carlo, additional, Marinangeli, Giancarlo, additional, Di Loreto, Ermanno, additional, Quarello, Francesco, additional, Forneris, Giacomo, additional, Tancredi, Maurizio, additional, Morosetti, Massimo, additional, Palombo, Giuditta, additional, Di Luca, Marina, additional, Martello, Mauro, additional, Emiliani, Giuseppe, additional, Bellazzi, Roberto, additional, and Stefoni, Sergio, additional

Published
2011
Full Text
View/download PDF

122. A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial

Author

Panichi, Vincenzo, primary, Rosati, Alberto, additional, Paoletti, Sabrina, additional, Ferrandello, Paolo, additional, Migliori, Massimiliano, additional, Beati, Sara, additional, Bernabini, Giada, additional, Daini, Roberto, additional, Casani, Aldo, additional, Angelini, Daniela, additional, Parrini, Manuela, additional, Rossi, Arturo, additional, Petrone, Isabella, additional, Barsotti, Giuliano, additional, Donadio, Carlo, additional, Donati, Giaclì, additional, Grazi, Giovanni, additional, Manca Rizza, Giovanni, additional, Garosi, Guido, additional, Sansoni, Enrico, additional, Braccagni, Beatrice, additional, Sidoti, Antonino, additional, Boracelli, Donella, additional, Biagioli, Marina, additional, Moriconi, Luigi, additional, Finato, Viviana, additional, Mannarino, Antonio, additional, Grimaldi, Cristina, additional, Pansa, Filomena, additional, Imperiali, Patrizio, additional, Mura, Carlo, additional, Bianchi, Stefano, additional, and Bigazzi, Roberto, additional

Published
2011
Full Text
View/download PDF

127. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial

Author

Panichi, Vincenzo, primary, Manca-Rizza, Giovanni, additional, Paoletti, Sabrina, additional, Taccola, Daniele, additional, Consani, Cristina, additional, Filippi, Cristina, additional, Mantuano, Emanuela, additional, Sidoti, Antonino, additional, Grazi, Giovanni, additional, Antonelli, Alessandro, additional, Angelini, Daniela, additional, Petrone, Isabella, additional, Mura, Carlo, additional, Tolaini, Patricia, additional, Saloi, Franco, additional, Ghezzi, Paolo M., additional, Barsotti, Giuliano, additional, and Palla, Roberto, additional

Published
2005
Full Text
View/download PDF

128. Interleukin-8 Is a Powerful Prognostic Predictor of All-Cause and Cardiovascular Mortality in Dialytic Patients

Author

Panichi, Vincenzo, primary, Taccola, Daniele, additional, Rizza, Giovanni Manca, additional, Consani, Cristina, additional, Ghiadoni, Lorenzo, additional, Filippi, Cristina, additional, Cristofani, Renza, additional, Panicucci, Erica, additional, Migliori, Massimiliano, additional, Sidoti, Antonino, additional, Biagioli, Marina, additional, Boracelli, Donella, additional, Barsotti, Giuliano, additional, and Tetta, Ciro, additional

Published
2005
Full Text
View/download PDF

129. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients

Author

Panichi, Vincenzo, primary, Paoletti, Sabrina, additional, Mantuano, Emanuela, additional, Manca-Rizza, Giovanni, additional, Filippi, Cristina, additional, Santi, Samuele, additional, Taccola, Daniele, additional, Donadio, Carlo, additional, Tramonti, Gianfranco, additional, Innocenti, Maurizio, additional, Casto, Giuseppe, additional, Consani, Cristina, additional, Sbragia, Giulietta, additional, Franzoni, Ferdinando, additional, Galetta, Fabio, additional, Panicucci, Erica, additional, and Barsotti, Giuliano, additional

Published
2005
Full Text
View/download PDF

135. C-Reactive Protein and Interleukin-6 Levels Are Related to Renal Function in Predialytic Chronic Renal Failure

Author

Panichi, Vincenzo, primary, Migliori, Massimiliano, additional, De Pietro, Stefano, additional, Taccola, Daniele, additional, Bianchi, Anna Maria, additional, Giovannini, Luca, additional, Norpoth, Maria, additional, Metelli, Maria Rita, additional, Cristofani, Renza, additional, Bertelli, Alberto A.E., additional, Sbragia, Giulietta, additional, Tetta, Ciro, additional, and Palla, Roberto, additional

Published
2002
Full Text
View/download PDF

136. Renal Transplantation in Patients with Fabry Disease

Author

Sessa, Adalberto, primary, Meroni, Mietta, additional, Battini, Graziana, additional, Maglio, Alessia, additional, Nebuloni, Manuela, additional, Tosoni, Angela, additional, Panichi, Vincenzo, additional, and Bertagnolio, Barbara, additional

Published
2002
Full Text
View/download PDF

137. C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES

Author

Panichi, Vincenzo, primary, Migliori, Massimiliano, additional, De Pietro, Stefano, additional, Taccola, Daniele, additional, Bianchi, Anna Maria, additional, Norpoth, Maria, additional, Metelli, Maria Rita, additional, Giovannini, Luca, additional, Tetta, Ciro, additional, and Palla, Roberto, additional

Published
2001
Full Text
View/download PDF

140. Ultrasonic videodensitometric analysis of myocardium in end-stage renal disease treated with haemodialysis

Author

Di Bello, Vitantonio, primary, Panichi, Vincenzo, additional, Pedrinelli, Roberto, additional, Giorgi, Davide, additional, Bianchi, Massimiliano, additional, Bertini, Alessio, additional, Taccola, Daniele, additional, De Pietro, Stefano, additional, Talini, Enrica, additional, Paterni, Marco, additional, and Giusti, Costantino, additional

Published
1999
Full Text
View/download PDF

148. Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: Clinical and epidemiological implications.

Author

Maggiore, Umberto, Cristol, Jean-Paul, Canaud, Bernard, Dupuy, Angel Marie, Formica, Marco, Pozzato, Marco, Panichi, Vincenzo, Consani, Cristina, Metelli, Maria Rita, Sereni, Luisa, De Nitti, Concetta, David, Salvatore, and Tetta, Ciro

Abstract

Chronic inflammation has been repeatedly reported in individuals undergoing hemodialysis. C-reactive protein (CRP) is considered a marker of chronic inflammation, as well as a mediator of the atherosclerotic process. Clinical and epidemiologic studies are based on plasma values obtained with the use of various automated methods. Our aim was to test 3 commercially available methods and compare the values obtained with the use of these tests in a population of individuals undergoing hemodialysis. We compared the following methods: immunoturbidimetry (AU2700 biochemistry analyzer; Olympus, Rungis, France) laser nephelometry (Behring Diagnostics, Marburg, Germany), and nephelometry (Beckman Instruments, Fullerton, Calif. The 3 methods were used in 3 different centers: Montpellier, France; and Pisa and Turin, Italy, respectively. We prepared samples for the estimation of imprecision values (ie, coefficient of variation [CV]) from the plasma of normal patients by adding purified C-reactive protein at concentrations ranging from 2.6 to 180 mg/L for intraassay variation and concentrations of 0, 1, 2, 3, 5, 10, 20, 50, 100, 150, and 180 mg/L for interassay variation. Intraassay imprecision was determined with the use of 10 replicate analyses on the same sample of the same day. We assessed interassay imprecision using the same sample, divided into aliquots and measured on 5 consecutive days. Agreement between methods was assessed on predialysis serum samples collected from patients with stable chronic kidney disease who were undergoing long-term hemodialysis at the 3 different centers (Montpellier,192; Pisa, 56; Turin,98). Serum was separated from the red cells and stored in 3 aliquots at ?70°C until it could be analyzed. Samples were thawed only once, circulated among the 3 centers, and each tested with all 3 of the methods. The Beckman method yielded the most precise results, with intraassay CVs ranging from 1 to 2 and interassay CVs ranging from 1 to 4. The Behring method was the least precise, with intraassay and interassay CVs ranging from 12 to 15 and 7 to 16, respectively. The results of the Olympus method fell between those of the other 2 methods. Agreement between the results of the Olympus and Behring methods was satisfactorily. The Beckman and Olympus methods yielded, on average, similar results over the entire range of CRP values. We detected significant disagreement between the Beckman method and the other 2 methods, obtaining results 10 to 100 times lower with the Beckman method. This became evident in terms of ?-statistics. Our findings emphasize the need for careful assessment of the methods used to detect CRP in serum samples. Failure to do so may ultimately have a negative impact on the real relevance of CRP as a marker and on the role of chronic implication particularly in epidemiologic studies. [Copyright &y& Elsevier]

Published
2005
Full Text
View/download PDF

149. CLINICAL NEPHROLOGY - EPIDEMIOLOGY - CLINICAL TRIALS Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study.

Author

Mignani, Renzo, Panichi, Vincenzo, Giudicissi, Antonio, Taccola, Daniele, Boscaro, Francesca, Feletti, Carlo, Moneti, Gloriano, and Cagnoli, Leonardo

Subjects
*ENZYMES, *PATIENTS, *BETA (Finance), *KIDNEY transplantation, *THERAPEUTICS, *ELECTROCARDIOGRAPHY
Abstract

Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study. Background. We sought to assess the safety and efficacy of enzyme replacement therapy (ERT) with recombinant human-α-galactosidase A (rh-α-Gal A) in kidney transplant recipients with Fabry disease, a previously unstudied population. Methods. Three male kidney transplant recipients with biochemically, genetically, and histologically confirmed Fabry disease and documented Fabry myocardiopathy received the rh-α-Gal A, agalsidase beta, 1 mg/kg of body weight every 2 weeks by intravenous infusion and were monitored biochemically, clinically, and electrocardiographically and echocardiographically for 18 months. Results. Patients showed biochemical, clinical/functional, and morphologic response to ERT. Plasma globotriaosylceramide decreased 23% to 50%. Extremity pain resolved within 2 months in the patient with this manifestation. On echocardiography, left ventricular mass, end diastolic diameter (EDD), and cardiac contractility, shown by ejection fraction (EF), improved in 2 of the 3 patients receiving essentially all planned infusions. EDD and EF remained basically stable, but cardiac morphologic abnormalities progressed in the other patient, who had a 5-month interruption in ERT after the initial month. Mild mitral insufficiency persisted in all patients, as did atrial fibrillation in the affected individual. After a combined total of 116 infusions, no treatment-related adverse event, intolerance, or seroconversion was seen. Renal function remained stable and the immunosuppression regimen unchanged in all patients. Conclusion. Our pilot study provides preliminary evidence that ERT with agalsidase beta, 1 mg/kg every 2 weeks, is safe and often effective against extra-renal manifestations in kidney transplant patients with Fabry disease. Studies with longer courses of this and higher doses of ERT are merited in this population. [ABSTRACT FROM AUTHOR]

Published
2004
Full Text
View/download PDF

150. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

Author

Panichi, Vincenzo, Migliori, Massimiliano, Taccola, Daniele, Filippi, Cristina, De Nisco, Laura, Giovannini, Luca, Palla, Roberto, Tetta, Ciro, and Camussi, Giovanni

Subjects
*GLOMERULONEPHRITIS, *IMMUNOGLOBULINS, *VITAMIN D
Abstract

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Background. 1,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D3, is a potent immunomodulatory agent on several cell types such as monocytes and mesangial cells. Recruitment of inflammatory cells, as well as stimulation of resident cells and mesangial matrix accumulation are key features of various experimental and human glomerular diseases. Here we show that 1,25(OH)2D3 attenuates the morphologic and functional alterations in anti-Thy-1.1. nephritis, an experimental model of mesangial proliferative glomerulonephritis. Methods. The anti-Thy-1.1 group (group I) comprised 24 rats that at day 0 received 0.5 mL of saline containing 400 μg of monoclonal antibodies (mAb) anti-Thy-1.1 IgG. The anti-Thy-1.1 treated with 1,25(OH)2D3 group (group II) were 24 rats given 1,25(OH)2D3 at the dose of 25 ng/100 g body wt/day, from day -3 to day 14. At day 0, the rats received 400 μg of anti-Thy-1.1 monoclonal IgG. The control group (group III) comprised 12 rats injected with vehicle alone; the control group treated with 1,25(OH)2D3 (group IV)—12 rats were given 1,25(OH)2D3 as in group II without mAb administration. Proteinuria and urinary interleukin-6 excretion were measured daily. Blood urea nitrogen and creatinine, creatinine clearance, calcium, and phosphate were measured at days 0, 4, 7, and 14. In addition to conventional periodic acid-Schiff staining, binding of anti-Thy-1.1 IgG and C3b complement fraction, His48- and ED1–positive cells were studied by immunofluorescence. Mesangial proliferation was studied by the proliferating cell nuclear antigen (PCNA) technique. Apoptosis was evaluated by the TUNEL assay. Results. The anti-Thy-1.1 treated with 1,25(OH)2D3 group versus the anti-Thy-1.1 alone group showed a significant reduction in urinary protein (at day 7, 424 ± 228 vs. 66 ± 30 mg/mg urinary creatinine, P = 0.02) and interleukin-6 excretion (at day 3, 537 ± 360 pg/mL vs. 110 ± 34 pg/mg urinary creatinine, P = 0.015), reduced glomerular diameters (at day 7, 283 ± 38 vs. 261 ± 48 μm, P < 0.01), decreased neutrophil (at day 4, 20 ± 12 His48-positive cells/glomerulus vs. 3.7 ± 1.3 His48-positive cells/glomerulus, P < 0.001), and monocyte accumulation (day 7, 4.9 ± 2.9 ED1-positive cells/glomerulus vs. 2.8 ± 2.9 ED1-positive cells/glomerulus, P < 0.05), and attenuated glomerular cells proliferation (day 7, 13 ± 3.2 PCNA-positive cells/glomerulus vs. 9.4 ± 3 PCNA-positive cells/glomerulus, P < 0.01). Apoptosis showed a biphasic behavior with an early peak at day 4 in the anti-Thy-1.1 group (2.3 ± 2.2 TUNEL-positive cells/glom) related to cellular lysis and a late peak at day 14 related to the recovery phase. Conclusions. 1,25(OH)2D3 can reduce glomerular hypercellularity, inflammatory infiltration in anti-Thy-1.1 nephritis, preserving the apoptotic response of the reparative phase. [ABSTRACT FROM AUTHOR]

Published
2001
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results